You are here: Industry Insights > GlaxoSmithKline

News List

GSK Walks Away From Acquiring Pfizer Consumer Goods Unit biospace
March 26, 2018
GlaxoSmithKline will not make a play for Pfizer’s consumer health business.
GlaxoSmithKline seen as favourite to buy Pfizer's consumer healthcare unit after Reckitt Benckiser ends interest firstwordpharma
March 23, 2018
GlaxoSmithKline appears to be the frontrunner to buy Pfizer's consumer healthcare business after Reckitt Benckiser said that it ended its interest in the unit.
GSK Is Now Favorite to Acquire Pfizer's Consumer Health Business biospace
March 23, 2018
GlaxoSmithKline may have an easier path to acquiring Pfizer Inc.’s consumer health business after a rival suitor walked away from making a deal with the pharma giant.
GlaxoSmithKline Is Taking a Tough Approach to Budgets biospace
March 22, 2018
For some time now, GlaxoSmithKline in London, UK, has fallen behind its peers and its head of pharmaceuticals, Luke Mills, is pushing his department to work to cut the budget by 20%.
GlaxoSmithKline: Helping people do more, feel better, live longer biospace
March 22, 2018
There are numerous reasons for people to enter into the life sciences industry. It could be the desire to work with cutting-edge technology and research
Ionis Pharmaceuticals Partners With Akcea Therapeutics in a Potential $1.7 Billion Deal biospace
March 16, 2018
In 2017, GlaxoSmithKline ended its partnership with Ionis Pharmaceuticals, Inc. to develop and market inotersen and a follow-up drug for rare diseases
GSK’s Nucala improves control of severe asthma pharmatimes
March 07, 2018
GlaxoSmithKline has presented data showing that its biologic Nucala improved asthma control in patients with severe disease not adequately managed with Novartis’ Xolair.
GlaxoSmithKline notifies SEC, DOJ of new questions in China bribery probe fiercepharma
February 09, 2018
The U.K. drugmaker has now been asked for new info from fraud investigators in its home country.
J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz biospace
January 29, 2018
Late in 2017, Johnson & Johnson indicated it was interested in selling its consumer health business. Several companies, including Johnson & Johnson, GlaxoSmithKline and Reckitt Benckiser have been interested, according to insiders
GSK wins case against Reckitt Benckiser over misleading ad campaign pharmafile
January 24, 2018
GlaxoSmithKline is celebrating the news that the British pharmaceutical giant won the legal battle with Reckitt Benckiser

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page